Walleye Capital
VIR icon

Walleye Capital’s Vir Biotechnology VIR Stock Holding History

Walleye Capital’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.6K Sell
4,200
-20,500
-83% -$163K ﹤0.01% 3963
2025
Q4 		$149K Sell
24,700
-89,900
-78% -$535K ﹤0.01% 3689
2025
Q3 		$654K Buy
114,600
+16,300
+17% +$83.3K ﹤0.01% 2404
2025
Q2 		$495K Buy
+98,300
New +$527K ﹤0.01% 2642
2024
Q4 		– Sell
-200
Closed -$1.5K – 5605
2024
Q3 		$1.5K Buy
+200
New +$1.74K ﹤0.01% 5114
2024
Q2 		– Sell
-3,500
Closed -$35.5K – 6042
2024
Q1 		$35.5K Hold
3,500
– – ﹤0.01% 4783
2023
Q4 		$35.2K Buy
3,500
+1,700
+94% +$15.5K ﹤0.01% 4383
2023
Q3 		$16.9K Buy
+1,800
New +$25.7K ﹤0.01% 4411

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return